BioXcel Therapeutics Inc (BTAI)
2.57
+0.01
(+0.39%)
USD |
NASDAQ |
May 03, 16:00
2.57
0.00 (0.00%)
After-Hours: 20:00
BioXcel Therapeutics 1 Year Total Returns (Daily): -88.49% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -88.49% |
May 02, 2024 | -87.69% |
May 01, 2024 | -87.79% |
April 30, 2024 | -87.78% |
April 29, 2024 | -87.49% |
April 26, 2024 | -87.45% |
April 25, 2024 | -87.57% |
April 24, 2024 | -88.17% |
April 23, 2024 | -86.60% |
April 22, 2024 | -87.14% |
April 19, 2024 | -86.94% |
April 18, 2024 | -87.95% |
April 17, 2024 | -87.94% |
April 16, 2024 | -85.70% |
April 15, 2024 | -85.33% |
April 12, 2024 | -82.62% |
April 11, 2024 | -83.92% |
April 10, 2024 | -84.81% |
April 09, 2024 | -85.13% |
April 08, 2024 | -84.78% |
April 05, 2024 | -84.41% |
April 04, 2024 | -85.46% |
April 03, 2024 | -86.18% |
April 02, 2024 | -85.85% |
April 01, 2024 | -84.89% |
Date | Value |
---|---|
March 28, 2024 | -84.07% |
March 27, 2024 | -83.89% |
March 26, 2024 | -84.39% |
March 25, 2024 | -84.44% |
March 22, 2024 | -84.24% |
March 21, 2024 | -85.38% |
March 20, 2024 | -85.26% |
March 19, 2024 | -85.99% |
March 18, 2024 | -85.89% |
March 15, 2024 | -86.33% |
March 14, 2024 | -85.88% |
March 13, 2024 | -86.64% |
March 12, 2024 | -86.59% |
March 11, 2024 | -85.96% |
March 08, 2024 | -89.00% |
March 07, 2024 | -89.33% |
March 06, 2024 | -90.18% |
March 05, 2024 | -90.01% |
March 04, 2024 | -89.68% |
March 01, 2024 | -89.91% |
February 29, 2024 | -90.04% |
February 28, 2024 | -89.76% |
February 27, 2024 | -89.20% |
February 26, 2024 | -89.50% |
February 23, 2024 | -89.94% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.11%
Minimum
Feb 12 2024
1.28K%
Maximum
Nov 11 2020
67.68%
Average
-18.11%
Median
Oct 31 2019
1 Year Total Returns (Daily) Benchmarks
Synlogic Inc | -77.24% |
Cormedix Inc | 15.87% |
Bristol-Myers Squibb Co | -31.15% |
Verastem Inc | 106.4% |
Ocular Therapeutix Inc | -0.32% |